SAN FRANCISCO–Another J.P. Morgan Healthcare Conference is in the books, and biopharma’s movers, shakers and up-and-comers have headed back to Boston, Basel and Bangalore. This year, in the shadow of the best market for biotech IPOs since 2000, there’s fresh optimism that capital will continue to flow into drug developers’ pockets, whether via more market debuts or through the many top-tier VCs putting together new funds.

In this video, we take three minutes to poll four different biopharma leaders–ranging from Big Pharma dealmakers to angel-funded virtual companies–on the state of the industry. Below, we get more specific with these execs and a dozen more in a slide show of quotes and faces from the conference.

source link